ArticleDiabetologia2024

Genetic evidence for efficacy of targeting IL-2, IL-6 and TYK2 signalling in the prevention of type 1 diabetes: a Mendelian randomisation study.

Tea E Heikkilä et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.